{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:43:48Z","timestamp":1778607828292,"version":"3.51.4"},"reference-count":31,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.3892\/etm.2015.2634","type":"journal-article","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T08:29:29Z","timestamp":1436776169000},"page":"1084-1088","source":"Crossref","is-referenced-by-count":21,"title":["Retrospective analysis of the clinicopathological characteristics of gastrointestinal neuroendocrine neoplasms"],"prefix":"10.3892","volume":"10","author":[{"given":"ZHIQIANG","family":"WANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WENLIANG","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TIANXING","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUN","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LILIN","family":"LUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LIANYU","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BAOCUN","family":"SUN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RUI","family":"LIANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,7,13]]},"reference":[{"key":"key20180108123929_b1-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s004280100529","article-title":"Alterations of E-cadherin, alpha-catenin and beta-catenin expression in neuroendocrine tumors of the gastrointestinal tract","volume":"440","author":"Li","year":"2002","journal-title":"Virchows Arch"},{"key":"key20180108123929_b2-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.3748\/wjg.v19.i47.9012","article-title":"Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: Epidemiological changes in Germany","volume":"19","author":"Scher\u00fcbl","year":"2013","journal-title":"World J Gastroenterol"},{"key":"key20180108123929_b3-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u2018carcinoid\u2019: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180108123929_b4-etm-0-0-2634","volume-title":"World Health Organization Classification of Tumours of the Digestive System","author":"Bosman","year":"2010","edition":"4th"},{"key":"key20180108123929_b5-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00000658-199906000-00008","article-title":"Prognosis and survival in patients with gastrointestinal tract carcinoid tumors","volume":"229","author":"Shebani","year":"1999","journal-title":"Ann Surg"},{"key":"key20180108123929_b6-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jamcollsurg.2011.07.021","article-title":"The impact of incidental identification on the stage at presentation of lower gastrointestinal carcinoids","volume":"213","author":"Buitrago","year":"2011","journal-title":"J Am Coll Surg"},{"key":"key20180108123929_b7-etm-0-0-2634","first-page":"2946","article-title":"Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours","volume":"172","author":"Federspiel","year":"2010","journal-title":"Ugeskr Laeger"},{"key":"key20180108123929_b8-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2010.12.005","article-title":"The epidemiology of gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key20180108123929_b9-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4251\/wjgo.v6.i8.301","article-title":"Neuroendocrine tumors of the gastrointestinal tract: Case reports and literature review","volume":"6","author":"Salyers","year":"2014","journal-title":"World J Gastrointest Oncol"},{"key":"key20180108123929_b10-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.sla.0000129342.67174.67","article-title":"Updated population-based review of carcinoid tumors","volume":"240","author":"Maggard","year":"2004","journal-title":"Ann Surg"},{"key":"key20180108123929_b11-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/annonc\/mdq022","article-title":"Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Results from the National Cancer Registry of Spain (RGETNE)","volume":"21","author":"Garcia-Carbonero","year":"2010","journal-title":"Ann Oncol"},{"key":"key20180108123929_b12-etm-0-0-2634","first-page":"426","article-title":"Carcinoid tumors of the duodenum","volume":"1","author":"Oberndorfer","year":"1907","journal-title":"Frankfurter Zeitschrift f\u00fcr Pathologie"},{"key":"key20180108123929_b13-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(63)90951-6","article-title":"The classification of carcinoid tumours","volume":"1","author":"Williams","year":"1963","journal-title":"Lancet"},{"key":"key20180108123929_b14-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fonc.2013.00002","article-title":"Histopathology of gastrointestinal neuroendocrine neoplasms","volume":"3","author":"Hirabayashi","year":"2013","journal-title":"Front Oncol"},{"key":"key20180108123929_b15-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000355612","article-title":"Clinical and prognostic features of rectal neuroendocrine tumors","volume":"98","author":"Weinstock","year":"2013","journal-title":"Neuroendocrinology"},{"key":"key20180108123929_b16-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jamcollsurg.2008.08.013","article-title":"Proposed staging system for colon carcinoid tumors based on an analysis of 2,459 patients","volume":"207","author":"Landry","year":"2008","journal-title":"J Am Coll Surg"},{"key":"key20180108123929_b17-etm-0-0-2634","first-page":"243","article-title":"Surgical prognostic factors of gastroenteropancreatic neuroendocrine tumors (GEP NET)","volume":"50","author":"Medrano-Guzm\u00e1n","year":"2012","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"key20180108123929_b18-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1743-7563.2011.01423.x","article-title":"Gastroenteropancreatic neuroendocrine tumors: Incidence and treatment outcome in a single institution in Korea","volume":"7","author":"Lim","year":"2011","journal-title":"Asia Pac J Clin Oncol"},{"key":"key20180108123929_b19-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/MPA.0b013e318225483c","article-title":"Prognostic clinicopathologic factors in longitudinally followed patients with metastatic small bowel carcinoid tumors","volume":"40","author":"Curran","year":"2011","journal-title":"Pancreas"},{"key":"key20180108123929_b20-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000333853","article-title":"Chromogranin A is a reliable biomarker for gastroenteropancreatic neuroendocrine tumors in an Asian population of patients","volume":"95","author":"Chou","year":"2012","journal-title":"Neuroendocrinology"},{"key":"key20180108123929_b21-etm-0-0-2634","first-page":"5661","article-title":"Plasma chromogranin A levels predict survival and tumor response in patients with advanced gastroenteropancreatic neuroendocrine tumors","volume":"34","author":"Chou","year":"2014","journal-title":"Anticancer Res"},{"key":"key20180108123929_b22-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bpg.2012.12.005","article-title":"Surgery for GEP-NETs","volume":"26","author":"Knigge","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"key20180108123929_b23-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00423-011-0741-7","article-title":"Surgical treatment of gastrointestinal neuroendocrine tumors","volume":"396","author":"Fendrich","year":"2011","journal-title":"Langenbecks Arch Surg"},{"key":"key20180108123929_b24-etm-0-0-2634","first-page":"794","article-title":"Surgical management of neuroendocrine tumors of the gastrointestinal tract","volume":"25","author":"Huang","year":"2011","journal-title":"Oncology (Williston Park)"},{"key":"key20180108123929_b25-etm-0-0-2634","first-page":"843","article-title":"Surgical treatment of gastroentero-pancreatic neuroendocrine tumor","volume":"40","author":"Ohtsuka","year":"2013","journal-title":"Gan To Kagaku Ryoho"},{"key":"key20180108123929_b26-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11523-012-0230-0","article-title":"Place of surgical resection in the treatment strategy of gastrointestinal neuroendocrine tumors","volume":"7","author":"Gaujoux","year":"2012","journal-title":"Target Oncol"},{"key":"key20180108123929_b27-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4253\/wjge.v3.i7.133","article-title":"Management of early gastrointestinal neuroendocrine neoplasms","volume":"3","author":"Scher\u00fcbl","year":"2011","journal-title":"World J Gastrointest Endosc"},{"key":"key20180108123929_b28-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(11)61742-X","article-title":"RADIANT-2 Study Group: Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): A randomised, placebo-controlled, phase 3 study","volume":"378","author":"Pavel","year":"2011","journal-title":"Lancet"},{"key":"key20180108123929_b29-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ncponc1326","article-title":"Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors","volume":"6","author":"Reidy","year":"2009","journal-title":"Nat Clin Pract Oncol"},{"key":"key20180108123929_b30-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1586\/era.13.22","article-title":"Neuroendocrine neoplasms of the GI tract: The role of cytotoxic chemotherapy","volume":"13","author":"Khasraw","year":"2013","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20180108123929_b31-etm-0-0-2634","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1634\/theoncologist.2012-0263","article-title":"RADIANT-2 Study Group: Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: A subgroup analysis of the phase III RADIANT-2 study","volume":"18","author":"Castellano","year":"2013","journal-title":"Oncologist"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2015.2634\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T21:54:10Z","timestamp":1515448450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2015.2634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,13]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,7,13]]},"published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.3892\/etm.2015.2634"],"URL":"https:\/\/doi.org\/10.3892\/etm.2015.2634","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,13]]}}}